Literature DB >> 15286196

Penicillium marneffei: a pathogen on our doorstep?

Ferdinandos Skoulidis1, Marina S Morgan, Kenneth M MacLeod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15286196      PMCID： PMC1079563          DOI： 10.1177/014107680409700811

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  8 in total

Review 1.  Pathology of Penicillium marneffei. An emerging acquired immunodeficiency syndrome-related pathogen.

Authors:  C R Cooper; M R McGinnis
Journal:  Arch Pathol Lab Med       Date:  1997-08       Impact factor: 5.534

2.  Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients.

Authors:  T Sirisanthana; K Supparatpinyo; J Perriens; K E Nelson
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

3.  A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand.

Authors:  Suwat Chariyalertsak; Khuanchai Supparatpinyo; Thira Sirisanthana; Kenrad E Nelson
Journal:  Clin Infect Dis       Date:  2001-12-07       Impact factor: 9.079

4.  Cutaneous manifestations of Penicillium marneffei infection.

Authors:  Rataporn Ungpakorn
Journal:  Curr Opin Infect Dis       Date:  2000-04       Impact factor: 4.915

5.  A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus.

Authors:  K Supparatpinyo; J Perriens; K E Nelson; T Sirisanthana
Journal:  N Engl J Med       Date:  1998-12-10       Impact factor: 91.245

6.  Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.

Authors:  K Supparatpinyo; K E Nelson; W G Merz; B J Breslin; C R Cooper; C Kamwan; T Sirisanthana
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

7.  Disseminated Penicillium marneffei infection in southeast Asia.

Authors:  K Supparatpinyo; C Khamwan; V Baosoung; K E Nelson; T Sirisanthana
Journal:  Lancet       Date:  1994-07-09       Impact factor: 79.321

8.  Penicillium marneffei infection in patients with AIDS.

Authors:  T Sirisanthana
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883
  8 in total
  1 in total

1.  AIDS-associated Talaromyces marneffei central nervous system infection in patients of southwestern China.

Authors:  Yu-Ye Li; Rong-Jing Dong; Samip Shrestha; Pratishtha Upadhyay; Hui-Qin Li; Yi-Qun Kuang; Xin-Ping Yang; Yun-Gui Zhang
Journal:  AIDS Res Ther       Date:  2020-05-26       Impact factor: 2.250
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.